Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	413	255	297	931	1,923	2,116
Market Cap Growth	131.23%	-14.16%	-68.06%	-51.60%	-9.13%	4.57%
Enterprise Value	520	354	370	933	1,739	1,745
PE Ratio	-	-2.31	-1.63	-4.22	-8.46	-10.34
PS Ratio	3.12	2.01	2.76	10.78	21.69	14.50
PB Ratio	-12.33	-7.51	21.90	12.00	8.13	5.24
P/FCF Ratio	-9.31	-4.23	-2.00	-4.51	-10.03	-16.06
P/OCF Ratio	-9.59	-4.34	-2.02	-4.58	-10.40	-16.99
EV/Sales Ratio	3.94	2.79	3.43	10.80	19.62	11.95
EV/EBITDA Ratio	-6.76	-3.31	-2.07	-4.32	-7.69	-8.37
EV/EBIT Ratio	-6.51	-3.22	-2.04	-4.26	-7.59	-8.29
EV/FCF Ratio	-11.72	-5.87	-2.49	-4.52	-9.08	-13.25
Debt / Equity Ratio	-5.31	-5.29	11.60	2.06	0.10	0.05
Debt / EBITDA Ratio	-2.31	-1.68	-0.88	-0.74	-0.11	-0.09
Debt / FCF Ratio	-4.01	-2.98	-1.06	-0.77	-0.13	-0.15
Quick Ratio	1.82	1.76	1.66	2.72	2.44	4.46
Current Ratio	2.47	2.37	2.50	3.58	3.07	4.95
Asset Turnover	0.61	0.58	0.41	0.25	0.21	0.33
Interest Coverage	-159.62	-218.36	-216.73	-110.63	-	-
Return on Equity (ROE)	240.20%	393.20%	-1903.80%	-159.70%	-75.60%	-61.70%
Return on Assets (ROA)	-37.20%	-50.60%	-70.00%	-64.30%	-54.90%	-46.70%
Return on Capital (ROIC)	-56.63%	-75.94%	-102.11%	-92.26%	-87.38%	-49.74%
Earnings Yield	-19.61%	-43.34%	-61.24%	-23.71%	-11.82%	-9.68%
FCF Yield	-10.83%	-23.64%	-49.97%	-22.17%	-9.97%	-6.22%
Buyback Yield / Dilution	-26.80%	-26.87%	-10.57%	-8.48%	-11.00%	-11.73%
Total Shareholder Return	-26.80%	-26.87%	-10.57%	-8.48%	-11.00%	-11.73%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).